Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.
Vera Therapeutics (VERA) is drawing bullish attention from Wall Street, with multiple analysts significantly raising price targets following a key competitor's FDA approval and revised revenue forecasts for its lead drug candidate.
Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.
Kirby Corporation (NYSE: KEX) reported record annual earnings for 2025, fueled by robust free cash flow and strategic capital returns. While Q4 faced seasonal pressures, management highlighted a late-quarter rebound in inland marine and surging demand in power generation, setting the stage for what they project as a year of steady financial performance in 2026.
General Dynamics secures a major multi-year U.S. Navy contract for systems modernization, reinforcing its pivotal role in naval defense and underscoring the strength of its record order backlog amid robust segment performance.
Bloom Energy's stock surged after American Electric Power's subsidiary locked in a massive 20-year fuel cell agreement, a move analysts say validates the company's technology for critical infrastructure like AI data centers and signals a pivotal shift in its growth narrative.
Shares of the electronic brokerage firm edged higher after reporting strong monthly performance figures, fueled by a sustained rally in U.S. securities trading and significant growth in client activity.
As the U.S. grapples with surging energy demands from AI and data centers, a new wave of companies is emerging. We look at three speculative but promising energy stocks where a modest investment could tap into long-term structural shifts.
As semiconductor manufacturing grows more complex, KLA's process control systems are becoming indispensable. With a dominant market position and resilient financials, the company is positioned to capitalize on long-term industry trends, though its premium valuation invites scrutiny.
As data centers scramble to upgrade for the AI era, a critical bottleneck has emerged in optical communications. AXT, Inc., a specialist in compound semiconductor substrates, finds itself at the center of this shift, leveraging a unique supply chain advantage to meet explosive demand for indium phosphide.
Amid market uncertainty, Realty Income Corporation (O) is drawing investor attention for its unparalleled 55-year track record of monthly dividends. With a portfolio built for resilience, does this REIT offer a rare blend of safety and yield?
Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.
Palantir Technologies shatters expectations with Q4 results, reporting a 70% revenue surge and forecasting continued robust growth, as its AI platform becomes a central driver for U.S. commercial business.
Caterpillar, the industrial titan, rode the AI infrastructure wave to become the top-performing Dow stock in 2025. With record earnings on the horizon, investors are asking if its momentum can defy high valuations and continue into the new year.
In a landmark consolidation move, Devon Energy and Coterra Energy have agreed to an all-stock merger, positioning the combined entity as a dominant force in the prolific Delaware Basin. The deal signals a strategic shift towards scale and capital efficiency in the U.S. shale sector.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
Fifth Third Bancorp has finalized its acquisition of Comerica Incorporated, a move that consolidates the Midwest banking landscape and creates the nation's ninth-largest bank with nearly $300 billion in assets.
Capital Management Corp significantly boosted its stake in the logistics and mailing solutions provider, signaling confidence in its financial recovery and cash generation despite a revenue dip.
Speculation mounts over a potential merger between Tesla and SpaceX, part of a broader strategic realignment under Elon Musk that could see Tesla shift focus from electric vehicles to humanoid robots and autonomous taxis, with xAI potentially in the mix.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
